Key Players in the Global Liver Cancer Diagnostics Market: Advancing Early Detection with Innovation and Precision

The global liver cancer diagnostics market is experiencing steady growth, driven by the rising prevalence of liver cancer, increasing awareness about early detection, and advancements in diagnostic technologies. Factors such as excessive alcohol consumption, viral infections like hepatitis B and C, and the growing incidence of fatty liver disease are contributing to the surge in liver cancer cases. The demand for non-invasive and highly accurate diagnostic methods, including liquid biopsies, biomarker-based tests, and advanced imaging techniques such as MRI and CT scans, is increasing. In addition, the integration of artificial intelligence (AI) in diagnostics is improving the speed and accuracy of liver cancer detection. However, high costs associated with advanced diagnostic procedures and limited access to early-stage screening in developing regions remain significant challenges.

Global Liver Cancer Diagnostics Market is valued at USD 7.52 billion in 2022 and is expected to reach USD 12.44 billion by 2030, with a growing CAGR of 6.5% during the forecast period 2023 to 2030.

To know more, visit https://www.databridgemarketresearch.com/es/reports/global-liver-cancer-diagnostics-market

Below are the Top Liver Cancer Diagnostics Companies with a Significant Market Share:

Rank	Company	Overview	Product Portfolio	Sales Geographical Coverage	Developments
1.	F. Hoffmann-La Roche Ltd.	Roche is a global leader in molecular and immunodiagnostics for liver cancer detection. The company offers cobas molecular testing platforms and Elecsys biomarker assays, including AFP (Alpha-Fetoprotein) and PIVKA-II, for early liver cancer detection. Roche’s focus on precision diagnostics and companion diagnostics enhances targeted treatment options for liver cancer patients.	Elecsys AFP Elecsys PIVKA-II Elecsys GAAD	North America, South America, Middle East and Africa, Asia-Pacific, and Europe	In August 2022, F. Hoffmann-La Roche Ltd. announced the launch of a Digital LightCycler System, which is a next generation digital PCR system that helps clinical researchers to better understand the nature of a patient's cancer, genetic disease, or infection.
2.	Koninklijke Philips N.V.	Philips specializes in medical imaging solutions for liver cancer diagnosis, offering advanced ultrasound, CT, and MRI systems. Its EPIQ and Affiniti ultrasound systems with elastography technology provide real-time liver stiffness measurements to assess fibrosis and liver cancer risks. Philips integrates AI-powered imaging tools to improve liver cancer detection and patient management.	General Imaging Ultrasound AMI Imaging systems CT Imaging systems	North America, South America, Middle East and Africa, Asia-Pacific, and Europe	In October 2022, koninklijke Philips N.V. announced two new advances in MR-only workflows to advance head and neck cancer radiotherapy imaging and simulation. The company's artificial intelligence enabled MRCAT Head and Neck radiotherapy application, which allows the use of MR as the sole or primary imaging modality for radiotherapy planning in the treatment of soft tissue tumors in the head and neck, along with the brain, pelvis, and prostate, has received FDA 510 (k) clearance and is commercially available in the U.S.
3.	Thermo Fisher Scientific Inc.	Thermo Fisher provides high-precision molecular, genomic, and proteomic solutions for liver cancer diagnostics. The company offers ELISA kits, next-generation sequencing (NGS) panels, and biomarker assays, including AFP and DCP (Des-gamma-carboxy prothrombin) tests, for early hepatocellular carcinoma (HCC) detection. Thermo Fisher’s Oncomine™ panels help in comprehensive genetic profiling of liver cancer.	Gibco Liver Cancer Cell Culture Starter Kit TaqMan OpenArray Human Liver Cancer Panel (Configurable)	North America, South America, Middle East and Africa, Asia-Pacific, and Europe	In October 2022, Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has entered into a definitive agreement to acquire the Binding Site Group, a global leader in specialty diagnostics.
4.	BD	BD specializes in flow cytometry, molecular diagnostics, and liquid biopsy solutions for liver cancer detection. The company provides BD Max molecular diagnostics and AFP biomarker tests for identifying liver cancer at an early stage. BD’s innovations in high-throughput screening and automated lab solutions improve liver cancer diagnostics and patient outcomes.	TruGuide Disposable Coaxial Biopsy Needle TruGuide Disposable Coaxial Biopsy Needle TruGuide Disposable Coaxial Biopsy Needle TruGuide Disposable Coaxial Biopsy Needle TruGuide Disposable Coaxial Biopsy Needle TruGuide Disposable Coaxial Biopsy Needle TruGuide Disposable Coaxial Biopsy Needle TruGuide Disposable Coaxial Biopsy Needle	North America, South America, Middle East and Africa, Asia-Pacific, and Europe	In November 2022, BD announced a grant of USD 652,000 to Valley-Mount Sinai Comprehensive Cancer Care to increase diversity, equity, and inclusion in cancer clinical trials. This funding helped the company to increase its product development in diagnostics.
5.	Siemens Healthcare GmbH	Siemens Healthineers is a leader in liver cancer imaging and biomarker testing, offering ADVIA Centaur and Atellica immunoassay systems for detecting AFP, DCP, and other liver cancer biomarkers. The company’s AI-powered imaging technologies, including liver elastography and MRI solutions, provide accurate and early liver cancer detection.	Computed Tomography Magnetic Resonance Imaging ACUSON Sequoia Ultrasound System ACUSON Redwood Ultrasound System ACUSON Juniper Ultrasound Systems	North America, South America, Middle East and Africa, Asia-Pacific, and Europe	In August 2022, Siemens Healthcare GmbH has entered into an agreement with Varian Medical Systems, Inc. With this acquisition, Siemens Healthcare has helped in developing advanced solutions to treat against cancer and strengthen its position in the healthcare industry.

Conclusion

The global liver cancer diagnostics market is set for sustained growth as technological innovations enhance the accuracy and efficiency of early detection. Increased awareness campaigns, government initiatives, and research funding are further driving market expansion. While challenges such as affordability and accessibility persist, continued advancements in biomarker research, AI-powered diagnostics, and non-invasive testing methods will play a crucial role in improving early diagnosis and patient outcomes.

CHOOSE LICENCE TYPE

Enterprise User 7000
Single User 4800
DBMR Factbook 3200
DBMR Prime 8000
DBMR Nucleus 15000

Buy Now

Advance Formative Research Customization Request for bulk Reports

Latest News

Key Players in the Global Pemphigus Vulgaris Market: Advancing Rare Disease Treatments with Innovative Therapies

Key Players in the Global Liver Cancer Diagnostics Market: Advancing Early Detection with Innovation and Precision

Leading Players in the Global Cervical Cancer Diagnostic Market: Advancing Early Detection with Innovation and Precision

Leading Players in the Global Child Safety Seats Market: Innovation and Regulations Enhancing Child Passenger Protection

Key Players in the Global Cell Culture Media Market: Innovation and Advancements in Biopharmaceutical and Cell-Based Therapy Production

VIEW ALL

Client Testimonials

Marketing Director,

Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Product manager,

Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Investor relations,

GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Market Analyst,

Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Andrew - Senior Global Marketing Manager,

Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Amarildo - Manager, Global Strategic Alignment

MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Tor Hammer

Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro

Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department)

UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future

Claudio Rondena

Group Business Development & Strategic Marketing Director,
C.O.C Farmaceutici SRL

"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."

David Manning - Thermo Fisher Scientific

Director, Global Strategic Accounts,

Dear Ricky,
I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.

Manager - Market Analytics,

Uriah D. Avila - Zeus Polymer Solutions

Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.

Business Development Manager,

(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC

DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.

Business Intelligence and Analytics,

Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Competition Analyst,

Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.